Review
Published on 02 Aug 2024
Cross-talks between perivascular adipose tissue and neighbors: multifaceted nature of nereids
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442086
- 769 views
Type at least 3 characters
1,199 articles
Articles
Original Research
Published on 01 Aug 2024
Exploiting the anti-fibrotic effects of statins on thoracic aortic aneurysm progression: results from a meta-analysis and experimental data
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1426982
- 979 views
- 1 citation
Review
Published on 01 Aug 2024
The relationship of redox signaling with the risk for atherosclerosis
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430293
- 865 views
- 1 citation
Review
Published on 31 Jul 2024
NLRP3 inflammasome in atherosclerosis: Mechanisms and targeted therapies
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1430236
- 1,630 views
Original Research
Published on 31 Jul 2024
Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399248
- 1,539 views
- 1 citation
Original Research
Published on 30 Jul 2024
Autonomic modulation by SGLT2i or DPP4i in patients with diabetes favors cardiovascular outcomes as revealed by skin sympathetic nerve activity
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1424544
- 854 views
Review
Published on 30 Jul 2024
Research advances in the therapy of metabolic syndrome
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1364881
- 1,340 views
- 1 citation
Review
Published on 30 Jul 2024
Proprotein convertase subtilisin/kexin type 9 deficiency in extrahepatic tissues: emerging considerations
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413123
- 676 views
Original Research
Published on 29 Jul 2024
Effectiveness, safety, and treatment pattern of sodium zirconium cyclosilicate in Chinese patients with hyperkalemia: interim analysis from a multicenter, prospective, real-world study (Actualize Study)
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1398953
- 1,084 views
Original Research
Published on 26 Jul 2024
Muscular toxicity of colchicine combined with statins: a real-world study based on the FDA adverse event reporting system database from 2004–2023
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1418498
- 1,258 views
Editorial
Published on 25 Jul 2024
Editorial: Pharmacological therapy in patients with arrhythmias
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1465539
- 511 views
Review
Published on 25 Jul 2024
Implications of endoplasmic reticulum stress and autophagy in aging and cardiovascular diseases
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413853
- 1,044 views
Original Research
Published on 24 Jul 2024
Dynamic phenotypic shifts and M2 receptor downregulation in bladder smooth muscle cells induced by mirabegron
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1446831
- 986 views
Review
Published on 24 Jul 2024
Roles of distinct nuclear receptors in diabetic cardiomyopathy
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1423124
- 1,410 views
Original Research
Published on 23 Jul 2024
Garlic ameliorates atherosclerosis by regulating ferroptosis pathway: an integrated strategy of network pharmacology, bioinformatic and experimental verification
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1388540
- 1,912 views
Original Research
Published on 23 Jul 2024
Cystathionine γ-lyase inhibits mitochondrial oxidative stress by releasing H2S nearby through the AKT/NRF2 signaling pathway
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1374720
- 1,109 views